Dr Reddy's Laboratories Ltd
BSE:500124
Dr Reddy's Laboratories Ltd
BSE:500124
Price:
1 298.95
INR
1.95%
Market Closed
Market Cap:
₹216.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
IN |
|
U-Haul Holding Co
NYSE:UHAL
|
US |
|
G
|
Gipta Ofis Kirtasiye ve Promosyon Urunleri Imalat Sanayi AS
IST:GIPTA.E
|
TR |
|
Amal Ltd
BSE:506597
|
IN |
|
I
|
IDream Film Infrastructure Company Ltd
BSE:504375
|
IN |
|
C
|
Cardinal Health Inc
LSE:0HTG
|
US |
|
Y.A.C. Holdings Co Ltd
TSE:6298
|
JP |
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
H
|
Hainan Poly Pharm Co Ltd
SZSE:300630
|
CN |
|
A
|
Aquirian Ltd
ASX:AQN
|
AU |
|
Banner Corp
NASDAQ:BANR
|
US |
|
E
|
Enghouse Systems Ltd
OTC:EGHSF
|
CA |
|
JASTEC Co Ltd
TSE:9717
|
JP |
|
Reliance Global Holdings Ltd
HKEX:723
|
HK |
|
Qingdao Richen Food Co Ltd
SSE:603755
|
CN |
|
S
|
Shilp Gravures Ltd
BSE:513709
|
IN |
Relative Value
The Relative Value of one
DRREDDY
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 1 298.95 INR,
Dr Reddy's Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DRREDDY Relative Value
HIDDEN
Multiples Across Competitors
DRREDDY Competitors Multiples
Dr Reddy's Laboratories Ltd Competitors
Dr Reddy's Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
1.1T INR | 3 | 18.8 | 12 | 15.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.5 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
